OXYFLUX-300

Primarily indicated for the treatment of bovinerespiratory disease (BRD)
associated with Mannheimiahaemolytica, particularly where
an anti-inflammatoryand antipyretic effect is required.
• Additional efficacy against organisms sensitive tooxytetracycline,
including:- Pasteurella spp.- Arcanobacterium pyogenes-
Staphylococcus aureus- Certain Mycoplasma species.